Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

被引:2747
作者
Miller, Andrew H. [1 ]
Maletic, Vladimir [2 ]
Raison, Charles L.
机构
[1] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Univ S Carolina, Sch Med, Dept Neuropsychiat & Behav Sci, Columbia, SC USA
基金
美国国家卫生研究院;
关键词
Cytokines; depression; excitotoxicity; hypothalamic-pituitary-adrenal axis; inflammation; monoamines; stress; TUMOR-NECROSIS-FACTOR; INTERFERON-ALPHA THERAPY; INTERLEUKIN-1 RECEPTOR ANTAGONIST; INDUCED SICKNESS BEHAVIOR; ACTIVATED PROTEIN-KINASE; BREAST-CANCER SURVIVORS; PITUITARY-ADRENAL AXIS; PROINFLAMMATORY CYTOKINES; HIPPOCAMPAL NEUROGENESIS; RESISTANT DEPRESSION;
D O I
10.1016/j.biopsych.2008.11.029
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recognition that inflammation may represent a common mechanism of disease has been extended to include neuropsychiatric disorders including major depression. Patients with major depression have been found to exhibit increased peripheral blood inflammatory biomarkers, including inflammatory cytokines, which have been shown to access the brain and interact with virtually every pathophysiologic domain known to be involved in depression, including neurotransmitter metabolism, neuroendocrine function, and neural plasticity. Indeed, activation of inflammatory pathways within the brain is believed to contribute to a confluence of decreased neurotrophic support and altered glutamate release/reuptake, as well as oxidative stress, leading to excitotoxicity and loss of glial elements, consistent with neuropathologic findings that characterize depressive disorders. Further instantiating the link between inflammation and depression are data demonstrating that psychosocial stress, a well-known precipitant of mood disorders, is capable of stimulating inflammatory signaling molecules, including nuclear factor kappa B, in part, through activation of sympathetic nervous system outflow pathways. Interestingly, depressed patients with increased inflammatory biomarkers have been found to be more likely to exhibit treatment resistance, and in several studies, antidepressant therapy has been associated with decreased inflammatory responses. Finally, preliminary data from patients with inflammatory disorders, as well as medically healthy depressed patients, suggest that inhibiting proinflammatory cytokines or their signaling pathways may improve depressed mood and increase treatment response to conventional antidepressant medication. Translational implications of these findings include the unique opportunity to identify relevant patient populations, apply immune-targeted therapies, and monitor therapeutic efficacy at the level of the immune system in addition to behavior.
引用
收藏
页码:732 / 741
页数:10
相关论文
共 118 条
  • [61] Inflammation, glutamate, and glia in depression: A literature review
    McNally, Leah
    Bhagwagar, Zubin
    Hannestad, Jonas
    [J]. CNS SPECTRUMS, 2008, 13 (06) : 501 - 510
  • [62] The life, death, and replacement of oligodendrocytes in the adult CNS
    McTigue, Dana M.
    Tripathi, Richa B.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2008, 107 (01) : 1 - 19
  • [63] Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study
    Mendlewicz, Julien
    Kriwin, Philippe
    Oswald, Pierre
    Souery, Daniel
    Alboni, Silvia
    Brunello, Nicoletta
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (04) : 227 - 231
  • [64] Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome
    Meyers, CA
    Albitar, M
    Estey, E
    [J]. CANCER, 2005, 104 (04) : 788 - 793
  • [65] MILLER AH, 2008, BRAIN BEHAV IMMUN
  • [66] A functional genomic fingerprint of chronic stress in humans:: Blunted glucocorticoid and increased NF-κB signaling
    Miller, Gregory E.
    Chen, Edith
    Sze, Jasmen
    Marin, Teresa
    Arevalo, Jesusa M. G.
    Doll, Richard
    Ma, Roy
    Cole, Steve W.
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 64 (04) : 266 - 272
  • [67] Consensus paper of the WFSBP task force on biological markers:: Biological markers in depression
    Moesner, Rainald
    Mikova, Olya
    Koutsilieri, Eleni
    Saoud, Mohamed
    Ehlis, Ann-Christine
    Mueller, Norbert
    Fallgatter, Andreas J.
    Riederer, Peter
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2007, 8 (03) : 141 - 174
  • [68] Morón JA, 2003, J NEUROSCI, V23, P8480
  • [69] Inflammatory markers and sleep disturbance in major depression
    Motivala, SJ
    Sarfatti, A
    Olmos, L
    Irwin, MR
    [J]. PSYCHOSOMATIC MEDICINE, 2005, 67 (02): : 187 - 194
  • [70] Depression, chronic diseases, and decrements in health: results from the World Health Surveys
    Moussavi, Saba
    Chatterji, Somnath
    Verdes, Emese
    Tandon, Ajay
    Patel, Vikram
    Ustun, Bedirhan
    [J]. LANCET, 2007, 370 (9590) : 851 - 858